Halozyme Therapeutics Inc (NASDAQ:HALO)

13.93
BATS BZX Real-Time Price
As of 2:00pm ET
 +0.62 / +4.66%
Today’s Change
6.88
Today|||52-Week Range
16.55
+44.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues12.0M18.4M14.6M30.4M
 
 
 
 
 
Cost of Goods Sold5.1M5.5M4.7M6.1M
 
 
 
 
 
Depreciation And Amortization397.0K443.0K464.0K--
 
 
 
 
 
Operating ExpensesGross Income6.4M12.5M9.5M24.2M
 
 
 
 
 
General Expenses31.7M27.4M28.5M28.1M
 
 
 
 
 
Research And Development21.4M18.6M19.9M19.7M
 
 
 
 
 
Total Operating Expenses37.2M33.3M33.6M34.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.2M-14.9M-19.0M-3.9M
 
 
 
 
 
Interest Expense On Debt1.4M1.5M1.4M1.4M
 
 
 
 
 
Other Expenses0.000.000.00-45.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.5M-16.3M-20.3M-5.3M
 
 
 
 
 
Net Income-26.5M-16.3M-20.3M-5.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS118.9M123.7M124.0M124.3M
 
 
 
 
 
Shares To Calculate EPS Diluted118.9M123.7M124.0M124.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.13-$0.16-$0.04
 
 
 
 
 
EPS Diluted-$0.22-$0.13-$0.16-$0.04
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account